Spots Global Cancer Trial Database for adenoid cystic carcinoma
Every month we try and update this database with for adenoid cystic carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Cabozantinib in Advanced Salivary Gland Cancer Patients | NCT03729297 | Salivary Gland ... | Cabozantinib | 18 Years - | Radboud University Medical Center | |
| Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC | NCT04140526 | Non Small Cell ... Advanced Solid ... Metastatic Mela... Metastatic Head... Metastatic Rena... Metastatic Colo... Sarcomas Metastatic Pros... Ovarian Cancer Small Cell Lung... Metastatic Brea... Pancreas Cancer Gastric Cancer Esophageal Canc... Gastroesophagea... Cervical Cancer Adenoid Cystic ... Salivary Gland ... Urothelial Carc... | ONC-392 Pembrolizumab Docetaxel | 18 Years - | OncoC4, Inc. | |
| Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC) | NCT02662608 | Adenoid Cystic ... | Brontictuzumab | 18 Years - | M.D. Anderson Cancer Center | |
| P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) | NCT04249947 | Prostatic Neopl... Neoplasms by Hi... Neoplasms, Pros... Prostate Cancer Metastatic Cast... Neoplasms Prostatic Neopl... Genital Neoplas... Urogenital Neop... Neoplasms by Si... Prostatic Disea... Salivary Gland ... Salivary Gland ... Adenoid Cystic ... Salivary Duct C... Mucoepidermoid ... Acinic Cell Tum... | P-PSMA-101 CAR-... Rimiducid | 18 Years - | Poseida Therapeutics, Inc. | |
| Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers | NCT03680560 | Solid Tumor HER-2 Protein O... | ACTR T Cell Pro... Trastuzumab | 18 Years - 75 Years | Cogent Biosciences, Inc. | |
| Study of RAD001 in Adenoid Cystic Carcinoma | NCT01152840 | Adenoid Cystic ... | RAD001 | 18 Years - | Seoul National University Hospital | |
| Cabozantinib in Advanced Salivary Gland Cancer Patients | NCT03729297 | Salivary Gland ... | Cabozantinib | 18 Years - | Radboud University Medical Center | |
| Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma | NCT02098538 | Adenoid Cystic ... | Regorafenib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck | NCT02775370 | Adenoid Cystic ... | Apatinib Mesyla... | 18 Years - 75 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
| A Study of SGN-B7H4V in Advanced Solid Tumors | NCT05194072 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... Triple Negative... HER2 Negative B... Hormone Recepto... Endometrial Neo... Carcinoma, Non-... Cholangiocarcin... Gallbladder Car... Adenoid Cystic ... | SGN-B7H4V | 18 Years - | Seagen Inc. | |
| AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer | NCT04973683 | Adenoid Cystic ... Metastatic Aden... | AL101 Therapeutic Con... | 18 Years - | M.D. Anderson Cancer Center | |
| Amivantamab in Adenoid Cystic Carcinoma | NCT05074940 | Salivary Gland ... | Amivantamab | 18 Years - | University of Cincinnati | |
| Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy | NCT01192087 | Adenoid Cystic ... | Cetuximab | 18 Years - 70 Years | Heidelberg University | |
| MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial | NCT03287427 | Colorectal Canc... Adenoid Cystic ... | TetMYB Vaccine BGB-A317 | 18 Years - | Peter MacCallum Cancer Centre, Australia | |
| A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma | NCT03999684 | Adenoid Cystic ... | Tretinoin | 18 Years - | Dana-Farber Cancer Institute | |
| 9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma | NCT04832438 | Salivary Gland ... Adenoid Cystic ... Salivary Gland ... Salivary Gland ... | 9-ING-41 Carboplatin | 18 Years - | Actuate Therapeutics Inc. | |
| Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma | NCT02780310 | Adenoid Cystic ... | Lenvatinib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Dovitinib in Adenoid Cystic Carcinoma | NCT01417143 | Adenoid Cystic ... | TKI258 (Dovitin... | 18 Years - | Seoul National University Hospital | |
| Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer | NCT04895735 | Metastatic Sali... Recurrent Saliv... Stage IV Major ... Adenoid Cystic ... | Pembrolizumab Pemetrexed Diso... Biospecimen Col... Computed Tomogr... Positron Emissi... Magnetic Resona... PSMA PET Scan | 18 Years - | Mayo Clinic | |
| Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation | NCT04214366 | Adenoid Cystic ... | Carbon ion irra... Bimodal irradia... | 18 Years - 80 Years | Heidelberg University | |
| APG-115 in Salivary Gland Cancer Trial | NCT03781986 | Malignant Saliv... Salivary Gland ... | APG-115 Carboplatin | 18 Years - | University of Michigan Rogel Cancer Center | |
| Amivantamab in Adenoid Cystic Carcinoma | NCT05074940 | Salivary Gland ... | Amivantamab | 18 Years - | University of Cincinnati | |
| Drug Screening Using Novel IMD in ACC and Salivary Cancers | NCT05553782 | Adenoid Cystic ... Adenoid Cystic ... | Implantable Mic... | 18 Years - | Dana-Farber Cancer Institute | |
| APG-115 in Salivary Gland Cancer Trial | NCT03781986 | Malignant Saliv... Salivary Gland ... | APG-115 Carboplatin | 18 Years - | University of Michigan Rogel Cancer Center | |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | NCT02834013 | Acinar Cell Car... Adenoid Cystic ... Adrenal Cortica... Adrenal Gland P... Anal Canal Neur... Anal Canal Undi... Angiosarcoma Apocrine Neopla... Appendix Mucino... Bartholin Gland... Basal Cell Carc... Bladder Adenoca... Breast Metaplas... Cervical Adenoc... Cholangiocarcin... Chordoma Colorectal Squa... Desmoid Fibroma... Endometrial Tra... Endometrioid Ad... Esophageal Neur... Esophageal Undi... Extrahepatic Bi... Extramammary Pa... Fallopian Tube ... Fallopian Tube ... Fibromyxoid Tum... Gallbladder Car... Gastric Neuroen... Gastric Squamou... Gastric Undiffe... Gastrointestina... Gestational Tro... Giant Cell Carc... Human Papilloma... Intestinal Neur... Intrahepatic Ch... Lung Neuroendoc... Lung Sarcomatoi... Major Salivary ... Malignant Odont... Malignant Perip... Malignant Solid... Malignant Testi... Metastatic Mali... Metastatic Pitu... Minimally Invas... Mixed Mesoderma... Mucinous Adenoc... Mucinous Cystad... Nasal Cavity Ad... Nasal Cavity Ca... Nasopharyngeal ... Nasopharyngeal ... Nasopharyngeal ... Oral Cavity Car... Oropharyngeal U... Ovarian Adenoca... Ovarian Germ Ce... Ovarian Mucinou... Ovarian Squamou... Ovarian Transit... Pancreatic Acin... Pancreatic Neur... Paraganglioma Paranasal Sinus... Paranasal Sinus... Parathyroid Gla... PEComa Penile Squamous... Peritoneal Meso... Placental Chori... Primary Periton... Pseudomyxoma Pe... Rare Disorder Scrotal Squamou... Seminal Vesicle... Seminoma Serous Cystaden... Small Intestina... Small Intestina... Spindle Cell Ne... Teratoma With S... Testicular Non-... Thyroid Gland C... Tracheal Carcin... Transitional Ce... Ureter Adenocar... Ureter Squamous... Urethral Adenoc... Urethral Squamo... Vaginal Adenoca... Vaginal Squamou... Vulvar Carcinom... | Biospecimen Col... Computed Tomogr... Echocardiograph... Ipilimumab Magnetic Resona... Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations | NCT03691207 | Adenoid Cystic ... | AL101 | 18 Years - | Ayala Pharmaceuticals, Inc, | |
| Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma | NCT01524692 | Adenoid Cystic ... | Dovitinib (TKI2... | 18 Years - | University of Virginia | |
| A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) | NCT04119453 | Adenoid Cystic ... | Rivoceranib | 18 Years - | Elevar Therapeutics | |
| Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma | NCT02942693 | Adenoid Cystic ... | Apatinib Particle Therap... | 18 Years - 65 Years | Shanghai Proton and Heavy Ion Center | |
| A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands | NCT00886132 | Adenoid Cystic ... Salivary Gland ... | Sunitinib | 18 Years - | University Health Network, Toronto | |
| Dovitinib in Adenoid Cystic Carcinoma | NCT01417143 | Adenoid Cystic ... | TKI258 (Dovitin... | 18 Years - | Seoul National University Hospital | |
| Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma | NCT02098538 | Adenoid Cystic ... | Regorafenib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Understanding the Burden of ACC Through the Eyes of Patients | NCT04706845 | Adenoid Cystic ... | 18 Years - | Ayala Pharmaceuticals, Inc, | ||
| A Study of XMT-1660 in Participants With Solid Tumors | NCT05377996 | Triple Negative... Breast Cancer Endometrial Can... Ovarian Cancer Fallopian Tube ... Primary Periton... Adenoid Cystic ... | XMT-1660 | 18 Years - | Mersana Therapeutics | |
| Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC | NCT04140526 | Non Small Cell ... Advanced Solid ... Metastatic Mela... Metastatic Head... Metastatic Rena... Metastatic Colo... Sarcomas Metastatic Pros... Ovarian Cancer Small Cell Lung... Metastatic Brea... Pancreas Cancer Gastric Cancer Esophageal Canc... Gastroesophagea... Cervical Cancer Adenoid Cystic ... Salivary Gland ... Urothelial Carc... | ONC-392 Pembrolizumab Docetaxel | 18 Years - | OncoC4, Inc. | |
| Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy | NCT01586767 | Adenoid Cystic ... Squamous Cell C... Sinonasal Carci... Sinonasal Undif... Mucoepidermoid ... Schneiderian Ca... Myoepithelial C... Esthesioneurobl... Melanoma | Proton radiatio... Intensity-modul... | 18 Years - | Massachusetts General Hospital | |
| Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer | NCT04895735 | Metastatic Sali... Recurrent Saliv... Stage IV Major ... Adenoid Cystic ... | Pembrolizumab Pemetrexed Diso... Biospecimen Col... Computed Tomogr... Positron Emissi... Magnetic Resona... PSMA PET Scan | 18 Years - | Mayo Clinic | |
| Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients | NCT04291300 | Salivary Gland ... Salivary Duct C... Adenoid Cystic ... | Lutetium-177-PS... | 18 Years - | Radboud University Medical Center | |
| CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC | NCT05774899 | Adenoid Cystic ... Metastatic Aden... Recurrent Adeno... | CB-103 Abemaciclib Lenvatinib | 18 Years - | Dana-Farber Cancer Institute | |
| A Study of XMT-1660 in Participants With Solid Tumors | NCT05377996 | Triple Negative... Breast Cancer Endometrial Can... Ovarian Cancer Fallopian Tube ... Primary Periton... Adenoid Cystic ... | XMT-1660 | 18 Years - | Mersana Therapeutics | |
| Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma | NCT01558661 | Adenoid Cystic ... | AG-013736 (AXIT... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of REM-422 in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma | NCT06118086 | Adenoid Cystic ... Metastatic Aden... Recurrent Adeno... | REM-422 | 18 Years - | Remix Therapeutics | |
| Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617 | NCT04801264 | Adenoid Cystic ... | 68Ga-PSMA 1.85GBq (50 mCi... | 18 Years - 80 Years | Peking Union Medical College Hospital | |
| Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers | NCT04209660 | Adenoid Cystic ... Salivary Gland ... | Lenvatinib Pembrolizumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of REM-422 in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma | NCT06118086 | Adenoid Cystic ... Metastatic Aden... Recurrent Adeno... | REM-422 | 18 Years - | Remix Therapeutics | |
| Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma | NCT01558661 | Adenoid Cystic ... | AG-013736 (AXIT... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Amivantamab in Adenoid Cystic Carcinoma | NCT05074940 | Salivary Gland ... | Amivantamab | 18 Years - | University of Cincinnati | |
| Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma | NCT03087019 | Adenoid Cystic ... | Radiation Pembrolizumab | 18 Years - | Dana-Farber Cancer Institute | |
| 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma | NCT05010629 | Salivary Gland ... Recurrent Saliv... Metastatic Canc... Adenoid Cystic ... | 9-ING-41 Carboplatin | 18 Years - | Dana-Farber Cancer Institute | |
| A Study of SGN-B7H4V in Advanced Solid Tumors | NCT05194072 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... Triple Negative... HER2 Negative B... Hormone Recepto... Endometrial Neo... Carcinoma, Non-... Cholangiocarcin... Gallbladder Car... Adenoid Cystic ... | SGN-B7H4V | 18 Years - | Seagen Inc. | |
| Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial | NCT04883671 | Adenoid Cystic ... Metastatic Aden... | Standard of Car... SBRT | 18 Years - | Dana-Farber Cancer Institute | |
| 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma | NCT05010629 | Salivary Gland ... Recurrent Saliv... Metastatic Canc... Adenoid Cystic ... | 9-ING-41 Carboplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Study of RAD001 in Adenoid Cystic Carcinoma | NCT01152840 | Adenoid Cystic ... | RAD001 | 18 Years - | Seoul National University Hospital | |
| 9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma | NCT04832438 | Salivary Gland ... Adenoid Cystic ... Salivary Gland ... Salivary Gland ... | 9-ING-41 Carboplatin | 18 Years - | Actuate Therapeutics Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
